These findings suggest that the variant in TM6SF2 (rs58542926, E167K) promotes hepatic steatosis by way of reducing hepatic TAG mobilization and the bulk transfer of neutral lipids into VLDL particles, thereby resulting in hypocholesterolemia and hepatic retention of neutral lipids [119]. The gene discussed is TM6SF2; the disease is fatty liver disease.